Logo image of ALGRO.PA

GROLLEAU SACA (ALGRO.PA) Stock Fundamental Analysis

EPA:ALGRO - Euronext Paris - Matif - FR0014005ZM5 - Common Stock - Currency: EUR

3.1  0 (0%)

Fundamental Rating

3

ALGRO gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 0 industry peers in the Unkown industry. ALGRO has a bad profitability rating. Also its financial health evaluation is rather negative. ALGRO is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

ALGRO had negative earnings in the past year.
ALGRO had a positive operating cash flow in the past year.
In multiple years ALGRO reported negative net income over the last 5 years.
Each year in the past 5 years ALGRO had a positive operating cash flow.
ALGRO.PA Yearly Net Income VS EBIT VS OCF VS FCFALGRO.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 1M -1M 2M -2M -3M

1.2 Ratios

Industry RankSector Rank
ROA -4.55%
ROE -12.22%
ROIC N/A
ROA(3y)-0.82%
ROA(5y)0.31%
ROE(3y)-2.62%
ROE(5y)-0.06%
ROIC(3y)N/A
ROIC(5y)N/A
ALGRO.PA Yearly ROA, ROE, ROICALGRO.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 5 -5 10 -10

1.3 Margins

In the last couple of years the Gross Margin of ALGRO has declined.
ALGRO does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 52.31%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.61%
GM growth 5YN/A
ALGRO.PA Yearly Profit, Operating, Gross MarginsALGRO.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 20 40

3

2. Health

2.1 Basic Checks

ALGRO does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ALGRO has about the same amount of shares outstanding.
The debt/assets ratio for ALGRO has been reduced compared to a year ago.
ALGRO.PA Yearly Shares OutstandingALGRO.PA Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 500K 1M 1.5M 2M 2.5M
ALGRO.PA Yearly Total Debt VS Total AssetsALGRO.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

ALGRO has an Altman-Z score of 1.87. This is not the best score and indicates that ALGRO is in the grey zone with still only limited risk for bankruptcy at the moment.
ALGRO has a Debt/Equity ratio of 0.49. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity 0.49
Debt/FCF N/A
Altman-Z 1.87
ROIC/WACCN/A
WACC6.68%
ALGRO.PA Yearly LT Debt VS Equity VS FCFALGRO.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 5M 10M

2.3 Liquidity

A Current Ratio of 1.60 indicates that ALGRO should not have too much problems paying its short term obligations.
A Quick Ratio of 1.14 indicates that ALGRO should not have too much problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 1.6
Quick Ratio 1.14
ALGRO.PA Yearly Current Assets VS Current LiabilitesALGRO.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

5

3. Growth

3.1 Past

The earnings per share for ALGRO have decreased strongly by -17827.59% in the last year.
The Revenue has grown by 17.09% in the past year. This is quite good.
Measured over the past years, ALGRO shows a very strong growth in Revenue. The Revenue has been growing by 21.30% on average per year.
EPS 1Y (TTM)-17827.59%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-259.73%
Revenue 1Y (TTM)17.09%
Revenue growth 3Y21.3%
Revenue growth 5YN/A
Sales Q2Q%55.58%

3.2 Future

ALGRO is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 82.57% yearly.
ALGRO is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.39% yearly.
EPS Next Y166.67%
EPS Next 2Y82.57%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year0%
Revenue Next 2Y8.17%
Revenue Next 3Y7.39%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ALGRO.PA Yearly Revenue VS EstimatesALGRO.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 10M 20M 30M 40M 50M
ALGRO.PA Yearly EPS VS EstimatesALGRO.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 0 0.2 -0.2 0.4

3

4. Valuation

4.1 Price/Earnings Ratio

ALGRO reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Based on the Price/Forward Earnings ratio of 15.05, the valuation of ALGRO can be described as correct.
ALGRO's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 34.04.
Industry RankSector Rank
PE N/A
Fwd PE 15.05
ALGRO.PA Price Earnings VS Forward Price EarningsALGRO.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 9.11
ALGRO.PA Per share dataALGRO.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10

4.3 Compensation for Growth

ALGRO's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as ALGRO's earnings are expected to grow with 82.57% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y82.57%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for ALGRO!.
Industry RankSector Rank
Dividend Yield N/A

GROLLEAU SACA

EPA:ALGRO (8/8/2025, 7:00:00 PM)

3.1

0 (0%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners3.69%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap8.80M
Analysts86.67
Price Target5.61 (80.97%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-26.67%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-31.26%
Revenue NY rev (3m)-31.26%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 15.05
P/S 0.22
P/FCF N/A
P/OCF 16.55
P/B 0.74
P/tB 0.98
EV/EBITDA 9.11
EPS(TTM)-0.51
EYN/A
EPS(NY)0.21
Fwd EY6.65%
FCF(TTM)-0.47
FCFYN/A
OCF(TTM)0.19
OCFY6.04%
SpS14.04
BVpS4.21
TBVpS3.18
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.55%
ROE -12.22%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 52.31%
FCFM N/A
ROA(3y)-0.82%
ROA(5y)0.31%
ROE(3y)-2.62%
ROE(5y)-0.06%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.61%
GM growth 5YN/A
F-Score4
Asset Turnover1.24
Health
Industry RankSector Rank
Debt/Equity 0.49
Debt/FCF N/A
Debt/EBITDA 4.71
Cap/Depr 95.12%
Cap/Sales 4.69%
Interest Coverage N/A
Cash Conversion 42.66%
Profit Quality N/A
Current Ratio 1.6
Quick Ratio 1.14
Altman-Z 1.87
F-Score4
WACC6.68%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)7.09%
Cap/Sales(5y)5.5%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-17827.59%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-259.73%
EPS Next Y166.67%
EPS Next 2Y82.57%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)17.09%
Revenue growth 3Y21.3%
Revenue growth 5YN/A
Sales Q2Q%55.58%
Revenue Next Year0%
Revenue Next 2Y8.17%
Revenue Next 3Y7.39%
Revenue Next 5YN/A
EBIT growth 1Y-2048.51%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1250%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y60.86%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-41.15%
OCF growth 3Y43.51%
OCF growth 5YN/A